Safety and complications of ocriplasmin: ocriplasmin, ocriplasmin; oh, how safe art thou? JAMA Ophthalmol 2014 Apr 01;132(4):379-80
Date
03/01/2014Pubmed ID
24577332DOI
10.1001/jamaophthalmol.2014.278Scopus ID
2-s2.0-84898655088 (requires institutional sign-in at Scopus site) 35 CitationsAuthor List
Kim JEMESH terms used to index this publication - Major topics in bold
Eye DiseasesFibrinolysin
Fibrinolytic Agents
Humans
Intravitreal Injections
Peptide Fragments
Retinal Diseases
Tissue Adhesions
Vision Disorders
Vitreous Body
